- Report
- March 2023
- 300 Pages
Global
From €4636EUR$4,799USD£3,964GBP
- Report
- February 2022
- 312 Pages
Global
From €2898EUR$3,000USD£2,478GBP
- Report
- February 2021
- 112 Pages
Global
From €1328EUR$1,375USD£1,136GBP
€2656EUR$2,750USD£2,271GBP
- Report
- April 2021
Global
From €3077EUR$3,185USD£2,631GBP
€4395EUR$4,550USD£3,758GBP
Cell therapy biomanufacturing is a rapidly growing field of biotechnology that involves the production of therapeutic cells for use in regenerative medicine. It involves the use of cell culture techniques to produce cells for therapeutic use, such as stem cells, immune cells, and other cell types. The process involves the isolation, expansion, and differentiation of cells, as well as the development of cell-based products. Cell therapy biomanufacturing is used to treat a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
Cell therapy biomanufacturing is a complex process that requires specialized equipment and expertise. It involves the use of advanced technologies such as cell sorting, gene editing, and cell culture systems. The process also requires the use of specialized reagents and media, as well as the development of quality control systems.
Companies in the cell therapy biomanufacturing market include Thermo Fisher Scientific, Lonza, Merck KGaA, GE Healthcare, and Sartorius. Show Less Read more